Purchase Order 75N98026P00832
- Not listed
- <p>The National Cancer Institute awarded a purchase order to Bioview (Usa), Inc. for service on the RiedLab's BioView automated scanner valued at $21,633.21, with an award date of March 2, 2016. Performance will take place in Bethesda, Maryland. The order is firm fixed price with an ultimate completion date of January 31, 2017.</p>
- The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $21,632 purchase order to Bioview (Usa), Inc., doing business as Bioview, to provide automated scanner services. The contract has a period of performance from July 25, 2023 through June 24, 2024. Under this firm fixed price award, Bioview will deliver its Bioview Automated Scanner to support the NIH NCI's research and diagnostic efforts. The place of performance will be Bioview's...
- <p>The National Cancer Institute issued a purchase order to Bioview (Usa), Inc. for $23,598.00 on April 3, 2019, with an ultimate completion date of April 2, 2020. The order is firm fixed price with no set-aside designation. Performance occurs in Bethesda, Maryland. The order procures medical imaging and diagnostic equipment, specifically automated cell analysis systems and related services for research support. No originating solicitation number is identified in the source.</p>
- The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $12,034 purchase order to Bioview (Usa), Inc., doing business as Bioview, to provide services in Bethesda, Maryland from August 2023 through February 2024. As a firm fixed price contract, Bioview will deliver unspecified services to support the NIH NCI's mission to conduct and coordinate research, training, health information dissemination, and other programs with respect to the...
- This is a $23,598.00 firm fixed-price purchase order awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Bioview (USA), Inc. for a service contract to provide the Bioview Automated Scanner. The contract has a period of performance through July 14, 2025. Bioview is a for-profit medical imaging and diagnostic equipment provider that specializes in automated cell analysis systems. This contract supports NCI's medical research initiatives by...
- The National Cancer Institute (NCI) awarded a firm-fixed-price purchase order contract worth $5,899.50 to Bioview (USA), Inc. for the provision of a Bioview Automated Scanner and associated services. The contract, which has a period of performance ending on March 31, 2025, supports medical research initiatives by delivering sophisticated scanning and imaging solutions. Bioview is a for-profit medical technology company that has been successfully competing for federal contracts, particularly with...
- Bioview (Usa), Inc. has been awarded a firm fixed price purchase order by the National Institutes of Health's National Cancer Institute for services supporting medical research efforts. With a potential value of $24,000, this sole source contract has no set aside designation and calls for Bioview to provide unspecified services at the agency's facility in Bethesda, Maryland through February 2027. As a laboratory equipment developer specializing in automated cell diagnostic systems, Bioview...
- The National Cancer Institute awarded a purchase order to Becton, Dickinson And Company for $4,512,844.80 on July 2, 2026, to provide maintenance services for 23 government-owned BD flow cytometers at the NIH Main Campus in Bethesda, Maryland. Services include two planned preventive maintenance inspections annually delivered by OEM-trained technicians, emergency repair services with one-hour initial response and 48-hour on-site visit commitment during standard business hours (8:00–17:00 EST,...
- <p>The National Cancer Institute awarded a purchase order to Sartorius Stedim North America Inc. for maintenance services on four Incucyte live cell image systems, with a ceiling value of $76,969.00 and an award date of May 1, 2026. Work is performed at Bethesda, Maryland. The order carries a firm fixed-price structure with an ultimate completion date of April 30, 2027. No small business set-aside applies.</p>
- <p>The National Cancer Institute awarded a purchase order to Biovision Technologies, Inc., a small business, on February 6, 2020, for a high-resolution camera for an existing microscope, with a ceiling value of $12,468.00. Work is performed in Exton, Pennsylvania, with an ultimate completion date of February 5, 2021. The order carries firm fixed pricing.</p>
The National Cancer Institute awarded a purchase order to Bioview (Usa), Inc. for maintenance services on a BioView Duet Automated Scanner, valued at $23,598.00, with an award date of August 1, 2026. The order carries a Total Small Business set-aside. Performance occurs at Bethesda, Maryland. Services include annual preventative maintenance, on-site repairs, replacement of worn components, software updates, and technical support via online and telephone for mission-critical equipment supporting cytogenetic studies and multiplexed Fluorescence in situ Hybridization assays at the Genetics Branch OMICS Technology Facility. The order is severable with an ultimate completion date of July 31, 2027. The procurement originated as Pre-Solicitation opportunity 75N98026Q00587, posted June 10, 2026, set aside for Total Small Business with a June 18, 2026 capability statement deadline.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Maintenance Contract for BioView Duet Automated Scanner | 75N98026Q00587 | Department of Health and Human Services National Institutes of Health Office of Logisitics and Acquisition Operations | Pre-Solicitation 1/1 | 6/10/26, 1:51 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.6k | 6/21/26 |